Feasibility and clinical value of TIPS combined with subsequent antitumor treatment in HCC patients with refractory ascites

BACKGROUND: Currently, hepatocellular carcinoma (HCC) patients with refractory ascites (RA) have a very poor prognosis, and there are no effective treatments recommended by the guidelines. A treatment strategy that utilizes a transjugular intrahepatic portosystemic shunt (TIPS) combined with subsequ...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Huzheng, Wang, Guobao, Zhu, Wenliang, Feng, Kai, Zhu, Wenke, Wu, Xuan, Qiu, Zhenkang, Chen, Guanyu, Jiang, Weiwei, Zhang, Fujun, Gao, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509227/
https://www.ncbi.nlm.nih.gov/pubmed/32950928
http://dx.doi.org/10.1016/j.tranon.2020.100864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509227/
https://www.ncbi.nlm.nih.gov/pubmed/32950928
http://dx.doi.org/10.1016/j.tranon.2020.100864

Ejemplares similares